C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.

Biochem Pharmacol 2009 Mar 27;77(6):1084-95. Epub 2008 Nov 27.

Department of Biochemistry and Molecular Biology and IBUB (Institute of Biomedicine University of Barcelona), Spain.

Central nervous system administration of C75 produces hypophagia and weight loss in rodents identifying C75 as a potential drug against obesity and type 2 diabetes. However, the mechanism underlying this effect is unknown. Here we show that C75-CoA is generated chemically, in vitro and in vivo from C75 and that it is a potent inhibitor of carnitine palmitoyltranferase 1 (CPT1), the rate-limiting step of fatty-acid oxidation. Three-D docking and kinetic analysis support the inhibitory effect of C75-CoA on CPT1. Central nervous system administration of C75 in rats led to C75-CoA production, inhibition of CPT1 and lower body weight and food intake. Our results suggest that inhibition of CPT1, and thus increased availability of fatty acids in the hypothalamus, contribute to the pharmacological mechanism of C75 to decrease food intake.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2008.11.020DOI Listing
March 2009
10 Citations
5.010 Impact Factor

Publication Analysis

Top Keywords

food intake
12
inhibition cpt1
8
body weight
8
administration c75
8
central nervous
8
system administration
8
nervous system
8
c75
6
potent inhibitor
4
weight food
4
c75 potent
4
mechanism underlying
4
diabetes mechanism
4
availability fatty
4
inhibitor carnitine
4
type diabetes
4
increased availability
4
underlying unknown
4
chemically vitro
4
generated chemically
4

Similar Publications